Cargando…
Understanding the Cellular Sources of the Fractional Exhaled Nitric Oxide (FeNO) and Its Role as a Biomarker of Type 2 Inflammation in Asthma
Fractional exhaled nitric oxide (FeNO) has gained great clinical importance as a biomarker of type 2 inflammation in chronic airway diseases such as asthma. FeNO originates primarily in the bronchial epithelium and is produced in large quantities by the enzyme inducible nitric oxide synthase (iNOS)....
Autores principales: | Escamilla-Gil, Jose M., Fernandez-Nieto, Mar, Acevedo, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085317/ https://www.ncbi.nlm.nih.gov/pubmed/35547356 http://dx.doi.org/10.1155/2022/5753524 |
Ejemplares similares
-
Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes
por: Gemicioglu, Bilun, et al.
Publicado: (2014) -
Fractional exhaled nitric oxide (FeNO) measurement in asthma and rhinitis
por: Gevorgyan, Artur, et al.
Publicado: (2013) -
Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023) -
296 The Relationship of Fractional Exhaled Nitric Oxide (FeNO) and Acute Exacerbation of Childhood Asthma
por: Rha, Yeong Ho, et al.
Publicado: (2012) -
Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews
por: Santillo, Marta, et al.
Publicado: (2022)